
Hancock Jaffe Laboratories, Inc. Revenue 2011-2026 | HJLI
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Hancock Jaffe Laboratories, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 4.25 K | 31.2 K | 187 K | 422 K | 786 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 786 K | 4.25 K | 286 K |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical devices industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Penumbra
PEN
|
1.4 B | $ 335.9 | 0.49 % | $ 13.1 B | ||
|
BioSig Technologies
BSGM
|
40 K | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
172 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
274 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
12.3 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
7.16 M | - | -26.83 % | $ 2.62 M | ||
|
Insulet Corporation
PODD
|
2.71 B | $ 220.08 | -2.4 % | $ 15.5 B | ||
|
Allied Healthcare Products
AHPI
|
6.02 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
1.59 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
1 K | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
7.2 M | $ 5.69 | 10.49 % | $ 180 M | ||
|
Quanterix Corporation
QTRX
|
139 M | $ 3.97 | 3.93 % | $ 169 M | ||
|
Conformis
CFMS
|
62 M | - | - | $ 16.4 M | ||
|
AVITA Medical
RCEL
|
71.6 M | $ 3.98 | 3.65 % | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
51.9 M | $ 1.34 | -1.11 % | $ 21.6 M | ||
|
IRadimed Corporation
IRMD
|
83.8 M | $ 102.42 | 1.44 % | $ 1.3 B | ||
|
Cardiovascular Systems
CSII
|
236 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
76.9 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
7.65 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
253 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
1.02 M | $ 2.6 | 0.97 % | $ 7.21 M | ||
|
CONMED Corporation
CNMD
|
1.37 B | $ 36.85 | 0.72 % | $ 1.14 B | ||
|
Smith & Nephew plc
SNN
|
4.56 B | $ 32.43 | 0.82 % | $ 23.8 B | ||
|
Sensus Healthcare
SRTS
|
27.5 M | $ 4.18 | 5.56 % | $ 68.2 M | ||
|
Itamar Medical Ltd.
ITMR
|
41 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
2.56 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
64 M | $ 24.83 | 0.53 % | $ 210 M | ||
|
Misonix, Inc.
MSON
|
62.5 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
2.55 M | - | - | $ 111 M | ||
|
Tactile Systems Technology
TCMD
|
330 M | $ 27.05 | 0.71 % | $ 619 M | ||
|
TELA Bio
TELA
|
58.5 M | $ 0.69 | -9.35 % | $ 15.8 M | ||
|
Intersect ENT, Inc.
XENT
|
80.6 M | - | - | $ 955 M | ||
|
Tandem Diabetes Care
TNDM
|
290 M | $ 24.5 | -0.04 % | $ 1.67 B | ||
|
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.67 | -4.17 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
574 K | $ 2.36 | 9.26 % | $ 3.68 M | ||
|
BIOLASE
BIOL
|
49.2 M | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
822 M | $ 11.84 | 0.98 % | $ 469 M | ||
|
InspireMD
NSPR
|
8.98 M | $ 1.76 | -1.68 % | $ 113 M | ||
|
AdaptHealth Corp.
AHCO
|
3.24 B | $ 11.35 | -1.13 % | $ 1.53 B | ||
|
Myomo
MYO
|
40.9 M | $ 0.7 | -1.07 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
1.3 M | $ 2.3 | -4.38 % | $ 135 M | ||
|
Invacare Corporation
IVC
|
181 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
44.1 M | $ 3.72 | -4.86 % | $ 139 M | ||
|
OrthoPediatrics Corp.
KIDS
|
236 M | $ 16.29 | 2.36 % | $ 382 M | ||
|
Outset Medical
OM
|
119 M | $ 3.53 | - | $ 53.7 K | ||
|
Varex Imaging Corporation
VREX
|
845 M | $ 10.71 | 0.85 % | $ 443 M |